Table 2.
Admission Lab Characteristics of 1122 Patients, Comparing Presence (n = 451) vs Absence (n = 671) of Diabetes and/or Uncontrolled Hyperglycemia.
| Variable | + Diabetes and/or uncontrolled hyperglycemia (n = 451) | – Diabetes or uncontrolled hyperglycemia (n = 671) | P-value |
|---|---|---|---|
| Mean blood glucose mg/dL (SD) | 202.4 (±117.7) | 114.5 (±20.0) | <.001 |
| Mean anion gap mEq/dL (SD)a | 15.8 (±6.3) | 13.4 (±4.9) | <.001 |
| Mean serum creatinine mg/dL (SD)b | 1.6 (±1.9) | 1.3 (±1.6) | .004 |
| Mean eGFR, mL/min (SD)c | 63.7 (±30.9) | 73.5 (±30.1) | <.001 |
| eGFR categories, mL/min | |||
| eGFR < 15, n (%) | 21 (4.8) | 28 (4.3) | .069 |
| eGFR 15-29, n (%) | 44 (10.0) | 18 (2.8) | <.001 |
| eGFR 30-59, n (%) | 113 (25.8) | 107 (16.4) | <.001 |
| eGFR ≥ 60, n (%) | 260 (59.4) | 499 (76.5) | <.001 |
Abbreviations: eGFR, estimated glomerular filtration rate; SD, standard deviation.
Anion gap was available in 431 of 451 patients with diabetes and/or uncontrolled hyperglycemia (95.6%) and in 651 of 671 patients without diabetes or uncontrolled hyperglycemia (97.5%).
Creatinine was available in 432 of 451 patients with diabetes and/or uncontrolled hyperglycemia (95.8%) and in 651 of 671 patients without diabetes or uncontrolled hyperglycemia (97.5%).
eGFR was available in 438 of 451 patients with diabetes and/or uncontrolled hyperglycemia patients (97.1%) and in 652 of 671 patients without diabetes or uncontrolled hyperglycemia (97.2%).